SCHEMBL18597765

SCHEMBL18597765

O=C(O)C(=O)N[C@H](Cc1ccc(-c2ccccc2)cc1Cl)CC(O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 1.00
▸ ACE P12821 17/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14890619 1.00 MME (1.00) MMEACE
SCHEMBL14891030 0.93 MME (0.87) MMEACE
SCHEMBL14890784 0.86 MME (1.00) MMEACE
SCHEMBL14890668 0.86 MME (1.00) MMEACE
SCHEMBL14891855 0.82 MME (0.70) MMEACE
SCHEMBL14890637 0.82 MME (0.79) MMEACE
SCHEMBL14890447 0.81 MME (1.00) MMEACE
SCHEMBL18597868 0.81 MME (1.00) MMEACE
SCHEMBL14890376 0.81 MME (1.00) MMEACE
SCHEMBL14900565 0.81 MME (1.00) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-B1 OXALIC ACID AMIDES AS NEPRILYSIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND PREPARATION THEREOF THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-03-08 — — EP disclosed
Send feedback